Intech Investment Management LLC Acquires 27,045 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Intech Investment Management LLC grew its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 179.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 42,124 shares of the company's stock after purchasing an additional 27,045 shares during the quarter. Intech Investment Management LLC owned approximately 0.07% of Astrana Health worth $1,328,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in ASTH. Handelsbanken Fonder AB increased its holdings in Astrana Health by 4.7% during the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock worth $281,000 after buying an additional 400 shares during the last quarter. Swiss National Bank grew its position in shares of Astrana Health by 1.1% during the 4th quarter. Swiss National Bank now owns 88,444 shares of the company's stock valued at $2,789,000 after acquiring an additional 1,000 shares during the period. KBC Group NV purchased a new stake in shares of Astrana Health during the 3rd quarter worth approximately $70,000. Quarry LP purchased a new stake in shares of Astrana Health during the 3rd quarter worth approximately $77,000. Finally, Moran Wealth Management LLC raised its holdings in shares of Astrana Health by 21.5% in the 4th quarter. Moran Wealth Management LLC now owns 7,944 shares of the company's stock worth $250,000 after purchasing an additional 1,404 shares during the period. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Price Performance

ASTH stock remained flat at $30.79 during mid-day trading on Wednesday. The company's stock had a trading volume of 159,180 shares, compared to its average volume of 361,996. The company has a 50-day moving average price of $34.00 and a two-hundred day moving average price of $42.26. Astrana Health, Inc. has a 1-year low of $23.12 and a 1-year high of $63.20. The stock has a market capitalization of $1.54 billion, a P/E ratio of 23.68, a P/E/G ratio of 1.37 and a beta of 1.30. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $665.21 million for the quarter, compared to analysts' expectations of $617.24 million. As a group, analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on ASTH shares. Truist Financial reduced their price objective on Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a report on Tuesday, March 18th. Bank of America decreased their price objective on Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a report on Tuesday, March 4th. Stifel Nicolaus lowered their price objective on Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research note on Thursday, February 20th. Macquarie upgraded shares of Astrana Health to a "hold" rating in a research report on Monday, December 16th. Finally, Robert W. Baird lowered their price target on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $56.17.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.